[1. Beedkar A, Parikh R, Deshmukh P. Heart Failure and the Iron Deficiency. J Assoc Physicians India. 2017;65:79-80.]Search in Google Scholar
[2. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-1023.10.1056/NEJMra041809]Search in Google Scholar
[3. Cairo G, Bernuzzi F, Recalcati S. A precious metal: Iron, an essential nutrient for all cells. Genes Nutr. 2006;1:25-39.10.1007/BF02829934]Search in Google Scholar
[4. Moos T. Brain iron homeostasis. Dan Med Bull. 2002;49;279-301.10.1023/A:1015866809087]Search in Google Scholar
[5. Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165:575-582.e310.1016/j.ahj.2013.01.017]Search in Google Scholar
[6. Comín-Colet J, Enjuanes C, González G, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013;15:1164-1172.10.1093/eurjhf/hft083]Open DOISearch in Google Scholar
[7. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015; 36:657-668.10.1093/eurheartj/ehu385]Search in Google Scholar
[8. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.10.1016/S0735-1097(00)00613-6]Search in Google Scholar
[9. van Veldhuisen DJ, Anker SD, Ponikowski P, et al. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011;8:485-493.10.1038/nrcardio.2011.7721629210]Search in Google Scholar
[10. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290:G199-G203.10.1152/ajpgi.00412.200516407589]Search in Google Scholar
[11. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski PP. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013;34:816-829.10.1093/eurheartj/ehs224359675923100285]Open DOISearch in Google Scholar
[12. Schaefer B, Effenberger M, Zoller H. Iron metabolism in transplantation. Transpl Int. 2014;27:1109-1117.10.1111/tri.1237424964028]Open DOISearch in Google Scholar
[13. Jankowska EA, Malyszko J, Ardehali H, et al. Iron status in patients with chronic heart failure. Eur Heart J. 2013;34:827-834.10.1093/eurheartj/ehs377369780323178646]Open DOISearch in Google Scholar
[14. von Haehling S, Anker MS, Jankowska EA, Ponikowski P, Anker SD. Anemia in chronic heart failure: can we treat? What to treat? Heart Fail Rev. 2012;17:203-210.10.1007/s10741-011-9283-x21979835]Open DOISearch in Google Scholar
[15. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872-1880.10.1093/eurheartj/ehq15820570952]Open DOISearch in Google Scholar
[16. Brunner-La Rocca HP, Crijns HJ. Iron i.v. in heart failure: ready for implementation? Eur Heart J. 2015;36:645-647.]Search in Google Scholar
[17. Nanas JN, Matsouka C, Karageorgopoulos D, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006;48:2485-2489.10.1016/j.jacc.2006.08.03417174186]Open DOISearch in Google Scholar
[18. Gstrein C, Meyer M, Anabitarte P. Iron substitution in the treatment of chronic heart failure. Swiss Med Wkly. 2017;100:w14453.10.4414/smw.2017.1445328695549]Search in Google Scholar
[19. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;18:2129-2200.10.1093/eurheartj/ehw12827206819]Open DOISearch in Google Scholar
[20. van der Meer P, Groenveld HF, Januzzi JL Jr, van Veldhuisen DJ. Erythropoietin treatment in patients with chronic heart failure: a metaanalysis. Heart. 2009;95:1309-1314.10.1136/hrt.2008.16109119168472]Search in Google Scholar
[21. Ponikowski P, Anker SD, Szachniewicz J, et al. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2007;49:753-762.10.1016/j.jacc.2006.11.02417306703]Search in Google Scholar
[22. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol. 2006;48:1225-1227.10.1016/j.jacc.2006.07.01516979010]Open DOISearch in Google Scholar
[23. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007;50:1657-1665.10.1016/j.jacc.2007.07.02917950147]Open DOISearch in Google Scholar
[24. Anker SD, Comin-Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436-2448.10.1056/NEJMoa090835519920054]Search in Google Scholar
[25. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36:657-668.10.1093/eurheartj/ehu385435935925176939]Search in Google Scholar
[26. Qian C, Wei B, Ding J, Wu H, Wang Y. The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis. Can J Cardiol. 2016;32:151-159.10.1016/j.cjca.2015.06.00926454467]Open DOISearch in Google Scholar
[27. Jankowska EA, Tkaczyszyn M, Suchocki T, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. 2016;18:786-795.10.1002/ejhf.47326821594]Open DOISearch in Google Scholar
[28. Miller HJ, Hu J, Valentine JK, Gable PS. Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease. Arch Intern Med. 2007;167:1327-1328.10.1001/archinte.167.12.132717592108]Search in Google Scholar
[29. McDonagh T, Macdougall IC. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail. 2015;17:248-262.]Search in Google Scholar
[30. Lewis GD, Malhotra R, Hernandez AF, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317:1958-1966.10.1001/jama.2017.5427570304428510680]Search in Google Scholar
[31. Beck-da-Silva L, Piardi D, Soder S, et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013;168:3439-3442.10.1016/j.ijcard.2013.04.18123680589]Search in Google Scholar
[32. Effectiveness of Intravenous Iron Treatment vs Standard Care in Patients With Heart Failure and Iron Deficiency: a Randomised, Open-label Multicentre Trial (IRONMAN) Available at: https://clinicaltrials.gov/ct2/show/NCT02642562]Search in Google Scholar
[33. Pereira DI, Mergler BI, Faria N, et al. Caco-2 cell acquisition of dietary iron(III) invokes a nanoparticulate endocytic pathway. PLoS One. 2013;8:e81250.10.1371/journal.pone.0081250383691324278403]Search in Google Scholar
[34. Pisani A, Riccio E, Sabbatini M, et al. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant. 2015;30:645-652.10.1093/ndt/gfu35725395392]Search in Google Scholar
[35. Latunde-Dada GO, Pereira DI, Tempest B, et al. A nanoparticulate ferritincore mimetic is well taken up by HuTu 80 duodenal cells and its absorption in mice is regulated by body iron. J Nutr. 2014;144:1896-1902.10.3945/jn.114.201715423020725342699]Search in Google Scholar
[36. Cleland JG, Zhang J, Pellicori P, et al. Prevalence and outcomes of anemia and haematinic deficiencies in patients with chronic heart failure. JAMA Cardiol. 2016;1:539-547.10.1001/jamacardio.2016.116127439011]Search in Google Scholar
[37. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-1276.10.1172/JCI200420945]Search in Google Scholar